Content uploaded by Carolyn Raina Elley
Author content
All content in this area was uploaded by Carolyn Raina Elley
Content may be subject to copyright.
Available via license: CC BY-NC-ND 3.0
Content may be subject to copyright.
Pedometers and Text Messaging to
Increase Physical Activity
Randomized controlled trial of adolescents with type 1 diabetes
KIRSTY H. NEWTON,
MPHC
1
ESKO J. WILTSHIRE,
MD, FRACP
2
C. RAINA ELLEY,
MBCHB, FRNZCGP, PHD
3
OBJECTIVE — To assess whether pedometers and text messaging increase physical activity
in adolescents with type 1 diabetes.
RESEARCH DESIGN AND METHODS — A 12-week randomized controlled trial was
conducted. A total of 78 subjects participated in the trial (mean ⫾SD age 14.4 ⫾2.37 years, 36
[47%] male). Intervention participants wore an open pedometer and received regular motiva-
tional text messages. Control participants received usual care. Primary outcomes were daily step
count (4-day closed pedometer) and physical activity questionnaire.
RESULTS — Baseline median step count was 11,063 steps/day (range 1,541–20,158). At 12
weeks, mean daily step count reduced by 840 (95% CI ⫺1,947 to 266) in the control group and
by 22 (⫺1,407 to 1,364) in the intervention group (P⫽0.4). Mean self-reported moderate or
vigorous physical activity increased by 38.5 min/week in the control group and by 48.4 in the
intervention group (P⫽0.9).
CONCLUSIONS — A 12-week intervention using pedometers and text messaging as moti-
vational tools in adolescents with type 1 diabetes did not increase physical activity.
Diabetes Care 32:813–815, 2009
A
dolescents with type 1 diabetes re-
quire ongoing care and support to
manage diabetes (1,2). Physical
activity is an important contributor to
glycemic control (3), has multiple ef-
fects on blood glucose, insulin sensitiv-
ity, weight management, mental health,
social development (4,5), and subse-
quent cardiovascular disease risk (6),
but may not be seen as a priority by
adolescents. Physical activity often de-
clines during adolescence because
physical education at school is no
longer compulsory; adolescents may
stop playing weekend sports, receive a
driver’s license, participate in after-
school programs, or receive weekend
jobs (7,8).
RESEARCH DESIGN AND
METHODS — A 12-week randomized
controlled trial was conducted in an out-
patient setting from four regional adoles-
cent diabetes services in New Zealand.
Participants were aged 11–18 years. In-
formed consent, enrollment information,
and baseline measurements were com-
pleted before randomization. Assessors
were blinded at follow-up.
Participants randomized to the inter-
vention group wore an open pedometer
every day for 12 weeks, with a goal of at
least 10,000 steps/day. A pedometer can
be opened by a participant to monitor and
record the number of steps taken. Steps
per day were recorded on a chart. Each
week, participants received a motiva-
tional text message reminding them to
wear a pedometer and be active. Individ-
uals randomized to the control group re-
ceived standard care.
Primary outcome measures were
change in physical activity measured by a
4-day step count from a closed pedometer
and self-reported physical activity over 7
days measured by a validated question-
naire (9,10). The pedometer was taped
shut so participants did not know the step
count. Secondary outcome measures in-
cluded A1C, blood pressure, BMI Zscore,
and quality of life (11). Adherence was
monitored in the intervention group by
weekly text messages and daily step total
charts, which were collected at follow-up.
It was estimated that 84 participants
would be required to detect, as statisti-
cally significant, a difference between the
groups of 2,000 steps/day or 1.5 h/week
of physical activity (␣⫽0.05; P⫽0.8)
(12). Baseline analyses were undertaken
using SPSS 15.0 statistical software. Lin-
ear regression was performed to assess fi-
nal differences between groups using
STATA 9.0. An intention-to-treat analysis
was conducted assuming participants
with missing follow-up data had no
change over 12 weeks. Where variables
were missing at baseline, these individu-
als were not included in final analyses for
those variables.
The trial was approved by the New
Zealand Central Regional Ethics Com-
mittee (CEN/05/08/058) and registered
with the Australian New Zealand Clini-
cal Trials Registry (clinical trial reg. no.
ACTRN012605000339651).
RESULTS — Of the 154 potentially eli-
gible participants at the clinics, 100 (65%)
were assed for eligibility and 78 (78%)
agreed to participate (Figure A1, available in
an online appendix at http://care.diabetes
journals.org/cgi/content/full/dc08-1974/
DC1). Forty subjects were randomized to
the control group and 38 to the intervention
group. Step counts were collected on all
participants at baseline. All 38 participants
allocated to the intervention group received
an open pedometer to wear for 12 weeks.
Three participants from the intervention
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
From the
1
Department of Primary Health Care and General Practice, University of Otago Wellington,
Wellington, New Zealand; the
2
Department of Pediatrics, University of Otago Wellington, Wellington,
New Zealand; and the
3
Department of Primary Health Care and General Practice, University of Auckland,
Auckland, New Zealand.
Corresponding author: Kirsty H. Newton, kirsty.newton@ccdhb.org.nz.
Received 3 November 2008 and accepted 10 February 2009.
Published ahead of print at http://care.diabetesjournals.org on 19 February 2009. DOI: 10.2337/dc08-1974.
Clinical trial reg. no. ACTRN012605000339651, actr.org.au.
© 2009 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Clinical Care/Education/Nutrition/Psychosocial Research
BRIEF REPORT
DIABETES CARE,VOLUME 32, NUMBER 5, MAY 2009 813
group and one from the control group
dropped out before the follow-up (5% attri-
tion rate).
At baseline, participants had a me-
dian step count of 11,063 steps/day
(range 1,541–20,158). Quality-of-life
scores were below the normative range of
60–80% Scale Maximum, suggesting a
lower quality of life in this group of ado-
lescents compared with that in others of
their age (13). Boys were significantly
more active than girls, with higher
mean ⫾SD daily step counts (12,420 ⫾
4,919 vs. 10,461 ⫾3,071 steps/day, re-
spectively; P⫽0.04), higher New Zea-
land Physical Activity Questionnaire
(NZPAQ) scores (837 ⫾522 vs. 580 ⫾
333 min/week; P⫽0.02), and lower BMI
Zscores (0.36 ⫾0.9 vs. 0.74 ⫾0.57; P⫽
0.03).
Table 1 presents baseline characteris-
tics and final results. At 12 weeks, there
was no significant difference in change in
activity measures between the groups.
Daily step count as measured by closed
pedometers decreased to a median (inter-
quartile range) of 10,159 steps/day
(8,014–14,109) in the intervention
group and 9,982 (8,090–12,465) in the
control group (P⫽0.2). Differences in
secondary outcomes were also not signif-
icant at 12 weeks for A1C, BMI Zscore,
quality of life, and blood pressure. There
was a trend toward lower quality of life in
the intervention group.
All 38 participants in the intervention
group were sent weekly text messages
over the 12-week intervention period un-
less they notified the principal researcher
that they had stopped wearing a pedom-
eter. Seventeen subjects (45%) lost their
pedometers, but they were all replaced.
Fourteen subjects (37%) stopped wearing
pedometers before the follow-up, al-
though eleven of these agreed to wear
4-day closed pedometers at follow-up
assessment.
CONCLUSIONS — Pedometers and
weekly text messaging as motivational
tools did not increase physical activity in
adolescents with type 1 diabetes over a
12-week period. Adherence to pedometer
use waned in the intervention group, with
37% discontinuing the intervention be-
fore the 12-week end measurements. Al-
though pedometers have a gadget appeal
among adolescents, the appeal was short
lived. More support in addition to a
weekly text message may be needed to
sustain interest.
Table 1—Baseline characteristics and mean changes in primary and secondary outcomes over 12 weeks
Baseline characteristics Mean change between baseline and follow-up*
Control† Intervention† Control‡ Intervention‡
Difference between
groups‡ P
n40 38
Primary outcome measures
Daily step count 10,900 (8,324–13,240) 11,242 (8,380–13,537) ⫺840 (⫺1,947 to 266) ⫺22 (⫺1,407 to 1,364) 819 (⫺916 to 2,554) 0.4
Moderate and vigorous physical
activity (min/week)§ 645 (298–895) 712 (420–1,000) 38.5 (⫺95 to 172) 48.4 (⫺89 to 185) 9.9 (⫺178 to 198) 0.9
Secondary outcome measures
A1C (%) 8.50 (7.55–9.3) 7.95 (7.3–9.1) ⫺0.02 (⫺0.38 to 0.34) 0.35 (⫺0.12 to 0.83) 0.38 (⫺0.21 to 0.96) 0.2
Systolic blood pressure (mmHg) 114 (104–123) 115 (106–126) ⫺2.1 (⫺9.1 to 4.8) ⫺0.0 (⫺8.8 to 8.8) 2.1 (⫺8.9 to 13.1) 0.7
Diastolic blood pressure (mmHg) 67 (60–72) 65 (60–67) ⫺2.0 (⫺6.8 to 2.8) ⫺0.7 (⫺6.2 to 4.9) 1.3 (⫺5.8 to 8.5) 0.7
BMI Zscore 0.64 (0.05–0.98) 0.62 (0.25–1.17) 0.016 (⫺0.08 to 0.11) 0.006 (⫺0.07 to 0.09) ⫺0.009 (⫺0.13 to 0.12) 0.9
Quality of life (SQOL) 54.9 (53.8–55.8) 55.0 (54.1–56.4) 0.21 (⫺0.18 to 0.61) ⫺0.71 (⫺1.59 to 0.17) ⫺0.93 (⫺1.86 to 0.00) 0.06
Other measures
Insulin total daily dose (units/kg) 1.1 (1–1.4) 1.2 (0.9–1.6) 0.013 (⫺0.023 to 0.12) 0.015 (⫺0.016 to 0.136) 0.002 (0.006–0.01) 0.6
*Intention-to-treat analysis assumed that in subjects whose follow-up data were missing (n⫽4关5%兴) there was no change in outcome variable between baseline and follow-up. †Median (interquartile range); ‡(95%
CI); §self-reported from the physical activity questionnaire (NZPAQ). SQOL, subjective quality of life (13).
Pedometers and text messaging
814 DIABETES CARE,VOLUME 32, NUMBER 5, MAY 2009
Because of the limited number of ad-
olescents with type 1 diabetes in the re-
gions of the study and the business of the
clinics, the sample size did not reach the
target of 84. Even with 84 participants,
the study would have been underpow-
ered to detect as statistically significant
the difference of 819 steps/day, instead of
2,000 estimated. Although participation
(78%) and study retention (95%) rates
were high, adherence to the intervention
was low (37% stopped wearing the
pedometer).
There were also potential biases in
self-report of physical activity (reliability
and overestimation of both physical activ-
ity and adherence to pedometers). In ad-
dition, participants could not be blinded
to allocation of the intervention, and the
motivating effect of the closed pedometer
(with reminder texts) at baseline and fol-
low-up may have inflated physical activity
estimates in both groups.
There is no consensus about an ap-
propriate target number of steps for ado-
lescents (14,15). Even so, involving
regular physical activity as part of their
management remains clinically important
and warrants further investigation as to
the best method of motivating adoles-
cents to be more physically active.
Acknowledgments— This study was funded
by the Wellington Medical Research Founda-
tion and Sport & Recreation New Zealand.
This study was funded in part by Novo Nor-
disk. No other potential conflicts of interest
relevant to this article were reported.
Parts of this study were presented in ab-
stract form at the annual scientific meeting of
the Australasian Paediatric Endocrine Group,
Broome, Australia, 15–18 October 2007.
References
1. Milton B, Holland P, Whitehead WM. The
social and economic consequences of
childhood-onset type 1 diabetes mellitus
across the lifecourse: a systematic review.
Diabet Med 2006;23:821–829
2. DIAMOND Project Group. Incidence and
trends of childhood type 1 diabetes world-
wide 1990–1999. Diabet Med 2006;23:
857–866
3. Bernardini AL, Vanelli M, Chiari G, Iov-
ane B, Gelmetti C, Vitale R, Errico MK.
Adherence to physical activity in young
people with type 1 diabetes. Acta Biomed
2004;75:153–157
4. Wolfsdorf JI. Improving diabetes control
in adolescents with type 1 diabetes. In
Practical Psychology for Diabetes Clinicians.
2nd ed. Anderson BJ, Rubin RR, Eds. Al-
exandria, Virginia, American Diabetes As-
sociation, 2002, p. 149–159
5. Hohepa M, Schofield G, Kolt G. Adoles-
cent obesity and physical inactivity. N Z
Med J 2004;117:U1210
6. Williams G, Pickup JC. Handbook of Dia-
betes. Oxford, U.K., Blackwell Science,
1998
7. Pender N. Motivation for physical activity
among children and adolescents. In An-
nual Review of Nursing Research. Fitz-
patrick JJ, Ed. New York, Springer
Publishing, 1998, p. 139–172
8. Richards R, Reeder AI, Darling H. Interest
and participation in selected sports
among New Zealand adolescents. N Z
Med J 2004;117:U906
9. McLean G, Tobias M. The New Zealand
Physical Activity Questionnaires: Report on
the Validation and Use of NZPAQ-LF and
NZPAQ-SF Self-Report Physical Activity
Survey Instruments. Wellington, New Zea-
land, SPARC, 2004
10. Moy K, McFarlane K, Scragg R, Robinson
S. Validation of MOH-Short and SPARC-
Long Physical Activity Questionnaires: Final
Report. Auckland, New Zealand, SPARC,
2003
11. Cummins RA. Comprehensive Quality of
Life Scale—School Version. 5th ed. Mel-
bourne, Australia, Deakin University,
1997
12. Elley CR, Kerse N, Swinburn B, Arroll B,
Robinson E. Measuring physical activity
in primary health care research: validity
and reliability of two questionnaires. N Z
Fam Physician 2003;30:171–180
13. Petito F, Cummins RA. Quality of life in
adolescence: the role of perceived control,
parenting style and social support. Behav
Change 2000;17:196–207
14. Tudor-Locke CE, Myers AM. Method-
ological considerations for researchers
and practitioners using pedometers to
measure physical (ambulatory) activity.
Res Q Exerc Sport 2001;72:1–12
15. Tudor-Locke C, Pangrazi RP, Corbin CB,
Rutherford WJ, Vincent SD, Raustorp A,
Tomson LM, Cuddihy TF. BMI-refer-
enced standards for recommended pe-
dometer-determined steps per day in
children. Prev Med 2004;38:857–864
Newton, Wiltshire, and Elley
DIABETES CARE,VOLUME 32, NUMBER 5, MAY 2009 815